Profile of the Pleximmune blood test for transplant rejection risk prediction

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert Review of Molecular Diagnostics

• Publication date

  2016-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737159.2016.1139455PMID 26760313PMCID PMC4965161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children

  2017cited by this paper
• Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation

  2015cited by this paper
• Pediatric small bowel transplantation

  2015cited by this paper
• Liver allograft fibrosis and minimization of immunosuppression

  2015cited by this paper
• Utility of an immune cell function assay to differentiate rejection from infectious enteritis in pediatric intestinal transplant recipients

  2014cited by this paper
• Mycophenolate mofetil in liver transplantation: a review.

  2013cited by this paper
• Beyond calcineurin inhibitors: emerging agents in kidney transplantation

  2013cited by this paper
• Allospecific CD154 + T‐cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation

  2012cited by this paper
• Progressive graft fibrosis and donor‐specific human leukocyte antigen antibodies in pediatric late liver allografts

  2012cited by this paper
• The FDA's humanitarian device exemption program.

  2011cited by this paper
• Allospecific CD154+ T-Cytotoxic Memory Cells Identify Recipients Experiencing Acute Cellular Rejection After Renal Transplantation

  2011cited by this paper
• Pretransplant Predictors of Survival After Intestinal Transplantation: Analysis of a Single-Center Experience of More Than 100 Transplants

  2010cited by this paper
• Mechanism of cellular rejection in transplantation

  2010cited by this paper
• Pediatric small bowel transplantation.

  2010cited by this paper
• Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.

  2009cited by this paper
• Five Hundred Intestinal and Multivisceral Transplantations at a Single Center: Major Advances With New Challenges

  2009cited by this paper
• Allospecific CD154+ T Cells Associate with Rejection Risk After Pediatric Liver Transplantation

  2008cited by this paper
• Risk Factors for Rejection and Infection in Pediatric Liver Transplantation

  2008cited by this paper
• Depletion of CD8 Memory T Cells for Induction of Tolerance of a Previously Transplanted Kidney Allograft

  2007cited by this paper
• Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children.

  2007cited by this paper
• Clinical Utilities of Peripheral Blood Gene Expression Profiling in the Management of Cardiac Transplant Patients

  2007cited by this paper
• Randomized Trial of Basiliximab Induction versus Steroid Therapy in Pediatric Liver Allograft Recipients Under Tacrolimus Immunosuppression

  2006cited by this paper
• Enhanced Donor‐Specific Alloreactivity Occurs Independently of Immunosuppression in Children with Early Liver Rejection

  2005cited by this paper
• Pre‐Transplant IFN‐γ ELISPOTs Are Associated with Post‐Transplant Renal Function in African American Renal Transplant Recipients

  2005cited by this paper
• A schema for histologic grading of small intestine allograft acute rejection

  2003cited by this paper
• Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin.

  1998cited by this paper
• Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.

  1998cited by this paper
• Banff schema for grading liver allograft rejection: An international consensus document

  1997cited by this paper
• AIDS Education and Training Centers fact sheet. U.S. Department of Health and Human Services Health Resources and Services Administration.

  1995cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper

• Intestinal and Multivisceral Transplantation: Where We Stand Today

  2026cites this paper
• Assessing the adequacy of immunosuppression in pediatric liver transplantation with immune Monitoring: Are we there yet?

  2025cites this paper
• Understanding the molecular bridges between the drugs and immune cell.

  2025cites this paper
• T‐cell infiltrate intensity is associated with delayed response to treatment in late acute cellular rejection in pediatric liver transplant recipients

  2023cites this paper
• Novel Noninvasive Biomarkers in Liver Transplantation: A Tool on the Doorstep of Clinical Utilization

  2023cites this paper
• Operational tolerance after pediatric composite liver‐pancreas‐intestine transplantation following severe graft‐versus‐host disease

  2021cites this paper
• Grant monitoring after intestinal transplantation.

  2021cites this paper
• Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences.

  2021cites this paper
• Steroid‐free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long‐term longitudinal follow‐up

  2021cites this paper
• Three decades' analysis of pediatric liver transplantation outcomes reveals limited long‐term improvements

  2021cites this paper
• The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment

  2020cites this paper
• Genomics and Liver Transplantation: Genomic Biomarkers for the Diagnosis of Acute Cellular Rejection

  2020cites this paper
• Incidence of Post-Liver Transplant Hepatic Dysfunction After Sustained Virologic Response Following Direct-Acting Anti-Hepatitis C Therapy.

  2020cites this paper
• Immune Cell Function Assay

  2020cites this paper
• Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

  2019cites this paper
• Eight-color panel for immune phenotype monitoring by flow cytometry.

  2019cites this paper
• Immunosuppression in Pediatric Liver Transplant

  2019cites this paper
• Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine

  2018cites this paper
• Characterization of T cell immunophenotypes in intestinal transplantation: A pilot study.

  2018cites this paper
• Policy Submission

  2017cites this paper